Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis Dorte.

Slides:

Advertisements

Similar presentations

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States David B. Seifer, M.D., Valerie.

Advertisements

What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Age at menarche: a predictor of diminished ovarian function?

Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome Elisabeth Lerchbaum,

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

Infertility evaluation and treatment among women in the United States

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D

Michael M. Alper, M.D. Fertility and Sterility

Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life Pekka Pinola, Ph.D., Katri Puukka,

The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women

Ramifications of adolescent menstrual cycles ≥42 days in young adults

Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A

Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials Ana Cobo, Ph.D., César Diaz, M.D.

Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J

The spectrum of androgen excess disorders

A model for predicting age at menopause in white women

Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome

Association of the −243 A→G polymorphism of the glutamate decarboxylase 2 gene with obesity in girls with premature pubarche Selma Feldman Witchel, M.D.,

Circulating vitamin D correlates with serum antimüllerian hormone levels in late- reproductive-aged women: Women's Interagency HIV Study Zaher O. Merhi,

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,

Temporal trends in clomiphene citrate use: a population-based study

Impact of fatness, insulin, and gynecological age on luteinizing hormone secretory dynamics in adolescent females Josephine Z. Kasa-Vubu, M.D., Vandana.

Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F

Iris G. Insogna, M. D. , Malinda S. Lee, M. D. , M. B. A. , Rebecca M

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

A comparison of blood spot vs

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data Michael L. Eisenberg, M.D., Shufeng Li,

Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome Héctor F. Escobar-Morreale,

A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome Dorte Glintborg, M.D., Ph.D.,

Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos

Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular.

Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis

Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study

Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens

Robert F. Casper, M.D. Fertility and Sterility

The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women.

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.

Serum luteinizing hormone levels are markedly increased and significantly correlated with Δ4-androstenedione levels in lean women with polycystic ovary.

Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis Laura P. Smith, M.D.,

Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism? Heather Cook, M.D., Kathleen Brennan,

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Increased secretion of amylin in women with polycystic ovary syndrome

ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome Lucas Bandeira Marchesan, B.Sc., Poli Mara Spritzer,

Jeanne M Manson, Ph. D. , Mary D Sammel, Ellen W Freeman, Ph. D

Fertility and Sterility

Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation Allison Styne-Gross, M.D., Karen.

Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D

Banu Ucar, M. D. , Volkan Noyan, M. D. , Osman Caglayan, M. D

Genome-wide linkage analysis to age at natural menopause in a community-based sample: the Framingham Heart Study Joanne M. Murabito, M.D. Sc.M., Qiong.

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Association of vitamin D intake and serum levels with fertility: results from the Lifestyle and Fertility Study June L. Fung, Ph.D., Terryl J. Hartman,

Fertility and Sterility: an evaluation

Paolo Moghetti, M.D. Fertility and Sterility

Rupal Shroff, B. S. , Craig H. Syrop, M. D. , William Davis, M. D

A critique of the Women’s Health Initiative hormone therapy study

Current evaluation of amenorrhea

Inappropriate gonadotropin secretion in polycystic ovary syndrome

True ovarian volume is underestimated by two-dimensional transvaginal ultrasound measurement Mikkel Rosendahl, M.D., Erik Ernst, Ph.D., Per Emil Rasmussen,

Ronald M. Yang, M. D. , Richard A. Fefferman, M. D. , Charles E

Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density Lubna Pal, M.B., B.S., John Norian, M.D.,

Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph

Clinical and laboratory characteristics of adolescents with both polycystic ovary disease and anorexia nervosa Orit Pinhas-Hamiel, M.D., Nurit Pilpel,

What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.

Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test Dimitrios Panidis, M.D., Ph.D., Dimitrios.

Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles

Presentation transcript:

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis Dorte Glintborg, M.D., Jan Erik Henriksen, M.D., Ph.D., Marianne Andersen, M.D., Ph.D., Claus Hagen, M.D., Dr.Sci., Jørgen Hangaard, M.D., Ph.D., Per Emil Rasmussen, M.D., Karoline Schousboe, M.D., Ph.D., Anne Pernille Hermann, M.D., Ph.D. Fertility and Sterility Volume 82, Issue 6, Pages 1570-1579 (December 2004) DOI: 10.1016/j.fertnstert.2004.06.040 Copyright © 2004 American Society for Reproductive Medicine Terms and Conditions

FIGURE 1 Suggested evaluation program for patients with a primary diagnosis of hirsutism. Medical history: periods, fertility, age of debut, duration of symptoms, galactorrhea. Clinical examination: body mass index (BMI), blood pressure, waist–hip ratio, Ferriman-Gallwey score, virilization, Cushing's syndrome. Metabolism: fasting glucose, fasting insulin, fasting lipid profile. Hormone status: total T, serum hormone-binding globulin, LH, FSH, PRL, TSH. Fertility and Sterility 2004 82, 1570-1579DOI: (10.1016/j.fertnstert.2004.06.040) Copyright © 2004 American Society for Reproductive Medicine Terms and Conditions